Lv1
70 积分 2025-03-26 加入
SHR-2004, A Novel Humanised Monoclonal Antibody Targeting Factor XI (FXI), For Preventing Venous Thromboembolism (VTE) In Patients Undergoing Surgery For Ovarian Cancer: A Randomised, Active-Control Phase 2 Study
2天前
求助中
Will Factor XI Inhibitors Replace Current Anticoagulants for Stroke Prevention in Atrial Fibrillation?
6天前
已完结
Asundexian versus Apixaban in Patients with Atrial Fibrillation
10天前
已完结
SHR-2004, A Novel Humanised Monoclonal Antibody Targeting Factor XI (FXI), For Preventing Venous Thromboembolism (VTE) In Patients Undergoing Surgery For Ovarian Cancer: A Randomised, Active-Control Phase 2 Study
10天前
已关闭
Atrial Fibrillation
12天前
已完结
Factor XI/XIa inhibitors versus direct oral anticoagulants in atrial fibrillation
12天前
已完结
Atrial Fibrillation—a Review of Course and Prognosis
13天前
已关闭
Cancer-Associated Venous Thromboembolism — Beyond 6 Months
14天前
已完结
Pharmacokinetic and pharmacodynamic insights from microfluidic intestine-on-a-chip models
15天前
已完结
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism
18天前
已完结
皖公网安备34019202002308
